Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12484 | 902 | 40.5 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
608 | 3 | CIRCULATING TUMOR CELLS//CEA//CYFRA 21 1 | 14209 |
1581 | 2 | CYFRA 21 1//CEA//CARCINOEMBRYONIC ANTIGEN | 7240 |
12484 | 1 | ANTI P53 ANTIBODIES//SERUM P53 ANTIBODY//P53 ANTIBODIES | 902 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTI P53 ANTIBODIES | authKW | 1003383 | 4% | 87% | 34 |
2 | SERUM P53 ANTIBODY | authKW | 744732 | 2% | 100% | 22 |
3 | P53 ANTIBODIES | authKW | 677817 | 3% | 69% | 29 |
4 | P53 AUTOANTIBODIES | authKW | 476034 | 2% | 94% | 15 |
5 | AUTOANTIBODIES | authKW | 251764 | 25% | 3% | 223 |
6 | SERPA | authKW | 210915 | 1% | 69% | 9 |
7 | HENAN TUMOR EPIDEMIOL | address | 178077 | 1% | 48% | 11 |
8 | ANTI P53 | authKW | 152329 | 1% | 75% | 6 |
9 | ONCIMMUNE LTD | address | 152329 | 1% | 75% | 6 |
10 | ANTI P53 AUTOANTIBODIES | authKW | 141046 | 1% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7384 | 47% | 0% | 423 |
2 | Biochemical Research Methods | 1197 | 13% | 0% | 116 |
3 | Medical Laboratory Technology | 435 | 4% | 0% | 35 |
4 | Immunology | 323 | 11% | 0% | 97 |
5 | Gastroenterology & Hepatology | 236 | 6% | 0% | 51 |
6 | Medicine, Research & Experimental | 88 | 5% | 0% | 44 |
7 | Biotechnology & Applied Microbiology | 45 | 5% | 0% | 41 |
8 | Toxicology | 39 | 3% | 0% | 25 |
9 | Respiratory System | 34 | 2% | 0% | 20 |
10 | Public, Environmental & Occupational Health | 29 | 4% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HENAN TUMOR EPIDEMIOL | 178077 | 1% | 48% | 11 |
2 | ONCIMMUNE LTD | 152329 | 1% | 75% | 6 |
3 | EXCELLENCE AUTOIMMUN CANC | 90268 | 0% | 67% | 4 |
4 | WM KECK AUTOIMMUNE DIS | 68592 | 2% | 14% | 15 |
5 | NIH SPONSORED BORDER BIOMED | 67703 | 0% | 100% | 2 |
6 | ORAL ONCOL GRP | 67703 | 0% | 100% | 2 |
7 | ONCOPROTE CLIN | 60930 | 0% | 60% | 3 |
8 | ENVIRONM RADIAT BIOL | 45134 | 0% | 67% | 2 |
9 | CLIN ONCOPROTE | 40292 | 1% | 24% | 5 |
10 | HARVARD PROTE | 38682 | 0% | 29% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROTEOMICS CLINICAL APPLICATIONS | 7184 | 2% | 2% | 14 |
2 | CANCER BIOMARKERS | 3513 | 1% | 1% | 8 |
3 | JOURNAL OF PROTEOME RESEARCH | 2189 | 2% | 0% | 20 |
4 | CANCER DETECTION AND PREVENTION | 2123 | 1% | 1% | 10 |
5 | INTERNATIONAL JOURNAL OF CANCER | 1895 | 4% | 0% | 34 |
6 | PROTEOMICS | 1888 | 2% | 0% | 18 |
7 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1688 | 2% | 0% | 22 |
8 | EXPERT REVIEW OF PROTEOMICS | 1653 | 1% | 1% | 6 |
9 | TUMOR BIOLOGY | 1566 | 2% | 0% | 17 |
10 | ANTICANCER RESEARCH | 1449 | 3% | 0% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTI P53 ANTIBODIES | 1003383 | 4% | 87% | 34 | Search ANTI+P53+ANTIBODIES | Search ANTI+P53+ANTIBODIES |
2 | SERUM P53 ANTIBODY | 744732 | 2% | 100% | 22 | Search SERUM+P53+ANTIBODY | Search SERUM+P53+ANTIBODY |
3 | P53 ANTIBODIES | 677817 | 3% | 69% | 29 | Search P53+ANTIBODIES | Search P53+ANTIBODIES |
4 | P53 AUTOANTIBODIES | 476034 | 2% | 94% | 15 | Search P53+AUTOANTIBODIES | Search P53+AUTOANTIBODIES |
5 | AUTOANTIBODIES | 251764 | 25% | 3% | 223 | Search AUTOANTIBODIES | Search AUTOANTIBODIES |
6 | SERPA | 210915 | 1% | 69% | 9 | Search SERPA | Search SERPA |
7 | ANTI P53 | 152329 | 1% | 75% | 6 | Search ANTI+P53 | Search ANTI+P53 |
8 | ANTI P53 AUTOANTIBODIES | 141046 | 1% | 83% | 5 | Search ANTI+P53+AUTOANTIBODIES | Search ANTI+P53+AUTOANTIBODIES |
9 | TUMOR ASSOCIATED ANTIGEN | 138417 | 6% | 8% | 50 | Search TUMOR+ASSOCIATED+ANTIGEN | Search TUMOR+ASSOCIATED+ANTIGEN |
10 | CANCER IMMUNODIAGNOSIS | 101554 | 0% | 100% | 3 | Search CANCER+IMMUNODIAGNOSIS | Search CANCER+IMMUNODIAGNOSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TAN, HT , LOW, J , LIM, SG , CHUNG, MCM , (2009) SERUM AUTOANTIBODIES AS BIOMARKERS FOR EARLY CANCER DETECTION.FEBS JOURNAL. VOL. 276. ISSUE 23. P. 6880 -6904 | 110 | 48% | 131 |
2 | SOUSSI, T , (2000) P53 ANTIBODIES IN THE SERA OF PATIENTS WITH VARIOUS TYPES OF CANCER: A REVIEW.CANCER RESEARCH. VOL. 60. ISSUE 7. P. 1777 -1788 | 87 | 66% | 355 |
3 | NOLEN, BM , LOKSHIN, AE , (2010) AUTOANTIBODIES FOR CANCER DETECTION: STILL CAUSE FOR EXCITEMENT?.CANCER BIOMARKERS. VOL. 6. ISSUE 5-6. P. 229 -245 | 77 | 57% | 3 |
4 | CHEN, HD , WERNER, S , TAO, S , ZORNIG, I , BRENNER, H , (2014) BLOOD AUTOANTIBODIES AGAINST TUMOR-ASSOCIATED ANTIGENS AS BIOMARKERS IN EARLY DETECTION OF COLORECTAL CANCER.CANCER LETTERS. VOL. 346. ISSUE 2. P. 178 -187 | 49 | 64% | 21 |
5 | XIA, J , SHI, J , WANG, P , SONG, C , WANG, K , ZHANG, J , YE, H , (2016) TUMOUR-ASSOCIATED AUTOANTIBODIES AS DIAGNOSTIC BIOMARKERS FOR BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.SCANDINAVIAN JOURNAL OF IMMUNOLOGY. VOL. 83. ISSUE 6. P. 393 -408 | 59 | 60% | 0 |
6 | ZAENKER, P , ZIMAN, MR , (2013) SEROLOGIC AUTOANTIBODIES AS DIAGNOSTIC CANCER BIOMARKERS-A REVIEW.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 22. ISSUE 12. P. 2161-2181 | 49 | 57% | 35 |
7 | HEO, CK , BAHK, YY , CHO, EW , (2012) TUMOR-ASSOCIATED AUTOANTIBODIES AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS.BMB REPORTS. VOL. 45. ISSUE 12. P. 677 -685 | 52 | 61% | 15 |
8 | ZHANG, HF , XIA, JF , WANG, KJ , ZHANG, JY , (2015) SERUM AUTOANTIBODIES IN THE EARLY DETECTION OF ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW.TUMOR BIOLOGY. VOL. 36. ISSUE 1. P. 95 -109 | 40 | 70% | 6 |
9 | REUSCHENBACH, M , DOEBERITZ, MV , WENTZENSEN, N , (2009) A SYSTEMATIC REVIEW OF HUMORAL IMMUNE RESPONSES AGAINST TUMOR ANTIGENS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 58. ISSUE 10. P. 1535 -1544 | 56 | 49% | 111 |
10 | SUPPIAH, A , GREENMAN, J , (2013) CLINICAL UTILITY OF ANTI-P53 AUTO-ANTIBODY: SYSTEMATIC REVIEW AND FOCUS ON COLORECTAL CANCER.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 19. ISSUE 29. P. 4651-4670 | 65 | 42% | 16 |
Classes with closest relation at Level 1 |